Evidence map›Paper›PMID 37727703›Full record

ArticleHorticulture research2023

The parallel biosynthesis routes of hyperoside from naringenin in

Yingying Wang, Zhirong Cui, Qianqian Li, Shuai Zhang, Yongyi Li, Xueyan Li, Lingyi Kong, Jun Luo

Abstract read
In one paragraph

Article in Horticulture research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Cutting-edge plant natural product pathway elucidation.Current opinion in biotechnology · 2024
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yingying WangJiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, Department of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
Zhirong CuiJiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, Department of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
Qianqian LiJiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, Department of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
Shuai ZhangJiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, Department of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
Yongyi LiJiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, Department of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
Xueyan LiJiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, Department of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
Lingyi KongJiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, Department of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
Jun LuoJiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, Department of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperoside is a bioactive flavonoid galactoside in both medicinal and edible plants. It plays an important physiological role in the growth of flower buds. However, the hyperoside biosynthesis pathway has not been systematically elucidated in plants, including its original source, Hypericaceae. Our group found abundant hyperoside in the flower buds of

Identifiers

PMID37727703
PMCPMC10506691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.